Literature DB >> 18175285

Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: a comprehensive meta-review.

Ashraf Mina1, Emmanuel J Favaloro, Jerry Koutts.   

Abstract

We review the association between disorders of endocrine function and hemostasis. The content of more than 570 review articles were appraised to provide the core of 81 key articles referenced in this chapter. The search method used MEDLINE and EMBASE electronic databases and the key words e NDOCRINE DYSFUNCTION, DIABETES, GRAVES' DISEASE, HYPOTHYROIDISM, HYPERTHYROIDISM, THYROTOXICOSIS, VON WILLEBRAND DISEASE, VON WILLEBRAND FACTOR, BLEEDING DISORDERS, PLATELETS DYSFUNCTION, HEMOSTASIS DYSFUNCTION, and REVIEW. Abnormalities of hemostasis, platelets, and endothelium and the presence of microparticles, abnormal expression of adhesion molecules, and elevated von Willebrand factor are all associated with cardiovascular disease and are also features of various endocrine disorders, including diabetes and its complications, insulin resistance, polycystic ovary syndrome, and various thyroid disorders. Related causes and associated factors, including obesity, alcohol, hyperlipidemia, omega fatty acids, vitamin D, serotonin, insulin-like growth factors, angiotensin-converting enzyme, and C-reactive protein, are also discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18175285     DOI: 10.1055/s-2007-1000372

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  7 in total

Review 1.  Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis.

Authors:  Héctor F Escobar-Morreale; Manuel Luque-Ramírez; Frank González
Journal:  Fertil Steril       Date:  2010-12-17       Impact factor: 7.329

2.  Non-Alcoholic Fatty Liver Disease (NAFLD) - Is it an Emerging Risk Factor for Coronary Artery Disease?: Preliminary study in a local Indian population.

Authors:  Manopriya Thiruvagounder; Shaheen Khan; Dhastagir S Sheriff
Journal:  Sultan Qaboos Univ Med J       Date:  2010-07-19

Review 3.  Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview.

Authors:  William B Hillegass; Brigitta C Brott; James C Dobbs; Silvio E Papapietro; Vijay K Misra; Gilbert J Zoghbi
Journal:  Vasc Health Risk Manag       Date:  2011-07-18

Review 4.  Hemostasis in Hypothyroidism and Autoimmune Thyroid Disorders.

Authors:  Arash Ordookhani; Kenneth D Burman
Journal:  Int J Endocrinol Metab       Date:  2017-03-09

Review 5.  The prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balance.

Authors:  Isabella Russo
Journal:  Scientifica (Cairo)       Date:  2012-08-30

6.  The changes in the endothelial function and haemostatic and inflammatory parameters in subclinical and overt hyperthyroidism.

Authors:  Anna Popławska-Kita; Katarzyna Siewko; Beata Telejko; Anna Modzelewska; Janusz Myśliwiec; Robert Milewski; Maria Górska; Małgorzata Szelachowska
Journal:  Int J Endocrinol       Date:  2013-12-03       Impact factor: 3.257

Review 7.  Thrombosis in Thyroid Cancer.

Authors:  Arash Ordookhani; Abbas Motazedi; Kenneth D Burman
Journal:  Int J Endocrinol Metab       Date:  2017-10-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.